title: Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis.
abstract: OBJECTIVE
  Recently, an association was found between Crohn's disease and the interleukin-23 receptor (IL-23R) gene. Since the IL-23/IL-17 pathway is known to associate with other autoimmune diseases, including rheumatoid arthritis (RA) and systemic sclerosis (SSc), we hypothesised that IL-23R could be a shared susceptibility gene.
  
  
  METHODS
  Groups of patients with rheumatoid arthritis (n = 412), systemic sclerosis (n = 224), Crohn's disease (n = 190) and healthy controls (n = 220) were genotyped for rs10889677 (exon-3'UTR C2370A), rs2201841, and rs1884444 variants; the first two have been shown to confer risk for Crohn's disease.
  
  
  RESULTS
  We observed an increased prevalence of the homozygous rs10889677 AA and homozygous rs2201841 CC genotypes both in the Crohn's disease and in the RA groups as compared to the controls (12.1%, 11.9% vs 5.91%, p<0.05; and 13.2%, 13.1% vs 5.91%, p<0.05), but not in the SSc patients. Logistic regression analysis revealed that bearing these alleles represent risk for the development of rheumatoid arthritis (chi(2) = 5.58, p = 0.018, OR = 2.15, 95% CI 1.14-4.06 for rs10889677; and chi(2) = 7.45, p = 0.006, OR = 2.40, 95% CI 1.28-4.51 for rs2201841). The rs1884444 allele, which has been previously reported as neutral for development of Crohn's disease, was also found neutral for all studied groups in the present study.
  
  
  CONCLUSIONS
  The data reported here provide direct evidence that some allelic variants or haplogroups of IL-23R represent independent risk factors for rheumatoid arthritis as well as Crohn's disease, but not for scleroderma.
authors.affiliation: Department of Medical Genetics and Child Development, University of Pécs, H-7624 Pécs, Szigeti út 12, Hungary.
authors.forename: B
authors.initials: B
authors.lastname: Faragó
authors.forename: L
authors.initials: L
authors.lastname: Magyari
authors.forename: E
authors.initials: E
authors.lastname: Sáfrány
authors.forename: V
authors.initials: V
authors.lastname: Csöngei
authors.forename: L
authors.initials: L
authors.lastname: Járomi
authors.forename: K
authors.initials: K
authors.lastname: Horvatovich
authors.forename: C
authors.initials: C
authors.lastname: Sipeky
authors.forename: A
authors.initials: A
authors.lastname: Maász
authors.forename: J
authors.initials: J
authors.lastname: Radics
authors.forename: A
authors.initials: A
authors.lastname: Gyetvai
authors.forename: Z
authors.initials: Z
authors.lastname: Szekanecz
authors.forename: L
authors.initials: L
authors.lastname: Czirják
authors.forename: B
authors.initials: B
authors.lastname: Melegh
mesh_terms: D001172:Arthritis, Rheumatoid / Q000235:genetics*; D001323:Autoantibodies / Q000032:analysis / Q000235:genetics; D003424:Crohn Disease / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D018123:Receptors, Interleukin / Q000032:analysis / Q000235:genetics*; D012595:Scleroderma, Systemic / Q000235:genetics*
chemical_list: D001323:Autoantibodies; C515500:IL23R protein, human; D018123:Receptors, Interleukin